Výsledky vyhledávání

Requirements of optimal MHC class I antigen presentation

Autor: Zöhrer, Katharina

Hintergrund: Ein wichtiger Ansatz in der Krebstherapie ist die Entwicklung von Impfstoffen, die durch Antigenpräsentation eine Immunantwort auslösen. Jedoch besteht unzureichende Kenntnis über die optimale Antigenpräsentation und mehrere Impfstof

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_____10650::65248f213a07274deaf46097bf647244

Zobrazit plný text záznamu

Akademický článek

MART-1 transcript is absent in PBMCs from Vitiligo patients

Autor: Bam Marpe, Bagchi Tamishraha

Publikováno v: Open Life Sciences, Vol 4, Iss 4, Pp 528-535 (2009)

Externí odkaz: https://doaj.org/article/a92a9a10096548e49fbdede7a9bca25c

Zobrazit plný text záznamu

Prime-boost immunization by both DNA vaccine and oncolytic adenovirus expressing GM-CSF and shRNA of TGF-β2 induces anti-tumor immune activation

Autor: Jae J. Song, So Young Kim, Yeonsoo Joo, Hye Jin Choi, Dongxu Kang, Joo Hang Kim

Publikováno v: Oncotarget

// So Young Kim 1, * , Dongxu Kang 1, 2, * , Hye Jin Choi 3 , Yeonsoo Joo 1, 4 , Joo-Hang Kim 5 , Jae J. Song 1, 4 1 Institute for Cancer Research, Yonsei University College of Medicine, Seoul, Korea 2 Department of Oncology, Affiliated Hospital of Y

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce649511a77367366c1834d7d2615a9e
https://doi.org/10.18632/oncotarget.15008

Zobrazit plný text záznamu

Antibodies as biomarker candidates for response and survival to checkpoint inhibitors in melanoma patients

Publikováno v: Fässler, Mirjam; Diem, Stefan; Mangana, Joanna; Hasan Ali, Omar; Berner, Fiamma; Bomze, David; Ring, Sandra; Niederer, Rebekka; Del Carmen Gil Cruz, Cristina; Pérez Shibayama, Christian Ivan; Krolik, Michal; Siano, Marco; Joerger, Markus; Recher, Mike; Risch, Lorenz; Güsewell, Sabine; Risch, Martin; Speiser, Daniel E; Ludewig, Burkhard; Levesque, Mitchell P; ... (2019). Antibodies as biomarker candidates for response and survival to checkpoint inhibitors in melanoma patients. Journal for immunotherapy of cancer, 7(1), p. 50. BioMed Central 10.1186/s40425-019-0523-2
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-12 (2019)
Journal for Immunotherapy of Cancer
Journal for immunotherapy of cancer, vol. 7, no. 1, pp. 50

Background Long-term survival of stage IV melanoma patients has improved significantly with the development of immune checkpoint inhibitors (CIs). Reliable biomarkers to predict response and clinical outcome are needed. Methods We investigated the ro

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c0383a55b6649492b2f23f1522734b4
https://boris.unibe.ch/174992/1/50.full.pdf

Zobrazit plný text záznamu

MART-1 transcript is absent in PBMCs from Vitiligo patients

Autor: Tamishraha Bagchi, Marpe Bam

Publikováno v: Open Life Sciences, Vol 4, Iss 4, Pp 528-535 (2009)

Mechanisms occurring in the thymus and periphery are responsible for the generation and maintenance of tolerance in the immune system. Various reports have shown that the existence of an antigen in the peripheral circulation results in tolerance indu

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b80c16953afd8cf087e9e14c095e9a47
https://doaj.org/article/a92a9a10096548e49fbdede7a9bca25c

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání